Skip to main content

Table 4 Multivariate model for the relative risk of treatment failure

From: Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial

Variable

Hazard ratio

95% CI

P

Treatment with AS/SP vs SP

0.2

0.1–0.6

0.004

Age > 7 years vs. age ≤ 7 years

0.3

0.1–0.9

0.033

Presence of a quintuple mutation vs. fewer mutations

3.2

1.3–7.5

0.009

Temperature Day 0 (°C)

1.5

1.1–2.2

0.020

  1. SP: sulphadoxine-pyrimethamine
  2. AS/SP: artesunate/sulphadoxine-pyrimethamine
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us